Fmoc-N-(2,4,6-trimethoxybenzyl)-glycine, 97%, 250mg

3-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 1g

2-(1H-Benzoimidazol-2-yl)-2H-[1,2,4]triazol-3-ylamine, 95.0%, 1g

6-Fluoroisoquinolin-1(2H)-one, 95.0%, 10g

3-Fluoro-5-isopropoxyphenylboronic acid, 95.0%, 5g

(R)-2-(2,5-Dimethoxyphenyl)thiazolidine-4-carboxylic acid, 95.0%, 1g

(S)-piperazine-2-carboxylic acid dihydrochloride, 95.0%, 5g

3,5-dimethyl-2'-(4-methylpiperazinomethyl) benzophenone, 97.0%, 1g

4-(4-nitrophenyl)-2,3-dihydro-1H-1,5-benzodiazepine, 95.0%, 2g

2,2-Dimethoxypropane-1,3-diol, 98.0%, 25g

4-(1H-Benzo[d][1,2,3]triazol-1-yl)butanoic acid, 98.0%, 1g

1,4-Diazepan-1-yl(2-thienyl)methanone, 1g

2-Dodecyl-7-phenyl[1]benzothieno[3,2-b][1]benzothiophene [for organic electronics]>99.5%(HPLC)1g